Health Care Higher on Inflation Hedging — Health Care Roundup
Provided by
Dow Jones
Health-care companies rose as traders bet the sector would fare better than other sectors if inflation remained strong.
Investors' concerns have flipped to inflation from banking weakness as a wave of bank runs appears to have abated and economic data exhibits surprising resilience.
Inflation expectations in the U.S., eurozone and the United Kingdom have moderated, but still foreshadow price growth ahead of central-bank targets, said economists at brokerage JPMorgan.
Scynexis shares surged after British drug giant GSK licensed one of its gynecological-condition treatments.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
March 30, 2023 16:56 ET (20:56 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
GE Aerospace Earnings: Fantastic Prospects for Stand-Alone Jet Engine Maker
-
Best Innovative Companies to Own: 2024 Edition
-
Truist Earnings: Expense Control Is Working and Near-Term Capital Flexibility Is Crucial to Growth
-
5 Growth Stocks to Buy From the Best Money Managers
-
Verizon Earnings: Price Increases Drive Solid Wireless Revenue Growth
-
2 Wide-Moat Stocks Trading at Rare Discounts
-
The Best Defensive Stocks to Buy
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?